Neoadjuvant PD-1 Blockade in Resectable Lung CancerPatrick M. Forde, Drew M. Pardoll, Janis M. Taube et al.|New England Journal of Medicine|2018Cited by 2.1k
HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation CyclophosphamideLeo Luznik, Ephraim J. Fuchs, Paul V. O’Donnell et al.|Biology of Blood and Marrow Transplantation|2008Cited by 1.9k
Mitochondrial DNA Quantity Increases with Histopathologic Grade in Premalignant and Malignant Head and Neck LesionsMichael M. Kim, Joseph A. Califano, John D. Clinger et al.|Clinical Cancer Research|2004Cited by 188
Improved Survival with Inhibitory Killer Immunoglobulin Receptor (KIR) Gene Mismatches and KIR Haplotype B Donors after Nonmyeloablative, HLA-Haploidentical Bone Marrow TransplantationHeather J. Symons, Ephraim J. Fuchs, Mary S. Leffell et al.|Biology of Blood and Marrow Transplantation|2009Cited by 183
Haploidentical BMT for severe aplastic anemia with intensive GVHD prophylaxis including posttransplant cyclophosphamideAmy E. DeZern, Robert A. Brodsky, Marianna Zahurak et al.|Blood Advances|2020Cited by 149